{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:14Z","timestamp":1791223574837,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Previously, we have documented that prenatal hypoxia can aggravate the cognitive impairment and <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>lzheimer's disease (<jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>) neuropathology in <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content><jats:sup>Swe<\/jats:sup>\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1<jats:sup>A246E<\/jats:sup> (<jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1) transgenic mice, and valproic acid (<jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>) can prevent hypoxia\u2010induced down\u2010regulation of \u03b2\u2010amyloid (A\u03b2) degradation enzyme neprilysin (<jats:styled-content style=\"fixed-case\">NEP<\/jats:styled-content>) in primary neurons. In this study, we have investigated the molecular mechanisms of VPA's anti\u2010AD effects and found that <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content> can reduce the prenatal hypoxia\u2010induced neuritic plaque formation and improve the learning deficits in the AD mouse model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The pregnant <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1 transgenic mice were exposed in a hypobaric chamber. Neuritic plaque staining, Morris water maze, and enzyme\u2010linked immunosorbent assay (<jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>) were used to detect the effects of <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content> on <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\u03b2 neuropathology, learning, and memory. Chromatin immunoprecipitation (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>h<jats:styled-content style=\"fixed-case\">IP<\/jats:styled-content>) assays and real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">RT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>) were used to determine the effect of <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content> on the histone3 acetylation (<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>3\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ce).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content> can inhibit neuritic plaque formation and improve the learning and memory in the prenatal hypoxic <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1 transgenic mice. In addition, <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content> treatment can decrease the soluble and insoluble <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\u03b242 levels and increase the <jats:styled-content style=\"fixed-case\">NEP<\/jats:styled-content> expression via up\u2010regulation of <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>3\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ce in the <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1 transgenic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Valproic acid is able to attenuate the prenatal hypoxia\u2010induced A\u03b2 neuropathology and learning and memory deficits via inhibiting the activation of histone deacetylase 1 (<jats:styled-content style=\"fixed-case\">HDAC<\/jats:styled-content>1), preventing the decrease in <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>3\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ce in the <jats:styled-content style=\"fixed-case\">NEP<\/jats:styled-content> promoter regions and reducing the down\u2010regulation of <jats:styled-content style=\"fixed-case\">NEP<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cns.12186","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T08:36:37Z","timestamp":1385973397000},"page":"209-217","source":"Crossref","is-referenced-by-count":46,"title":["Valproic Acid Reduces Neuritic Plaque Formation and Improves Learning Deficits in <scp>APP<\/scp><sup>Swe<\/sup>\/<scp>PS<\/scp>1<sup>A246E<\/sup> Transgenic Mice via Preventing the Prenatal Hypoxia\u2010Induced Down\u2010Regulation of Neprilysin"],"prefix":"10.1111","volume":"20","author":[{"given":"Zheng","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Neurology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China"},{"name":"State Key Laboratory of Medical Neurobiology Department of Neurology Huashan Hospital Fudan University Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Neurology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences, &amp; Shanghai Jiao Tong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences, &amp; Shanghai Jiao Tong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences, &amp; Shanghai Jiao Tong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[{"name":"Institute of Neurology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China"},{"name":"Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences, &amp; Shanghai Jiao Tong University School of Medicine Shanghai China"},{"name":"1<sup>st<\/sup> Affiliated Hospital Dalian Medical University Dalian China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.02.045"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(98)01363-4"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652407782564462"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(84)80190-4"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-1-5"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:22:1-2:5"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001854"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720507780362164"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0083-x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1385\/MN:26:2-3:283"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.12.016"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1179\/016164106X130506"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.10.011"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.06.012"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019229"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2009.07.033"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00855.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-007-9349-2"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000240463.87886.9a"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000150886.50187.30"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055863.87435.B2"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608856200"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209011"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720508783954785"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603469200"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.1125"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81656-6"},{"key":"e_1_2_7_29_1","first-page":"6456","article-title":"Histone H3\u2010lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5\u2010aza\u20102'\u2010deoxycytidine","volume":"62","author":"Nguyen CT","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/30764"},{"key":"e_1_2_7_31_1","first-page":"7213","article-title":"Dependence of histone modifications and gene expression on DNA hypermethylation in cancer","volume":"62","author":"Fahrner JA","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115050-00001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104309200"},{"key":"e_1_2_7_34_1","first-page":"361","article-title":"Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia","volume":"46","author":"Bidzan L","year":"2012","journal-title":"Psychiatr Pol"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205011310030005"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2011.03.006"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.03.041"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.04.041"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05772"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80974-5"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1986.tb00677.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3199.bloodjournal85113199"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.11.5723"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20494"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720508783954703"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-5839fje"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-006-9086-y"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606298103"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl253"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-7035-9"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00277-1"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710823105"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081588"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcns.12186","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.12186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:24:24Z","timestamp":1695489864000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.12186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1111\/cns.12186"],"URL":"https:\/\/doi.org\/10.1111\/cns.12186","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}